Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights
Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights
剖析Pacira Biosciences，了解分析师观点
Analysts' ratings for Pacira BioSciences (NASDAQ:PCRX) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
在过去的季度里，对Pacira BioSciences（纳斯达克：PCRX）的分析师评级从看好到看淡都有，共有6位分析师提供。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $47.17, along with a high estimate of $57.00 and a low estimate of $38.00. Experiencing a 2.54% decline, the current average is now lower than the previous average price target of $48.40.
为提供更深入的见解，分析师们已经制定了12个月的股价目标，平均目标为47.17美元，最高估值为57.00美元，最低估值为38.00美元。当前平均数下跌了2.54%，现在的平均目标价低于之前的平均目标价48.40美元。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：更深入的了解
A clear picture of Pacira...
通过对最近...
登录免费看全文
登录/注册